$ECYT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDOCYTE INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDOCYTE INC. Get notifications about new insider transactions in ENDOCYTE INC for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2013 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 12.94 | 14,000 | 181,160 | 14,000 | |
Jun 21 2013 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Option Exercise | A | 12.94 | 14,000 | 181,160 | 14,000 | |
Jun 21 2013 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Option Exercise | A | 12.94 | 14,000 | 181,160 | 14,000 | |
Jun 21 2013 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Option Exercise | A | 12.94 | 14,000 | 181,160 | 14,000 | |
May 29 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.25 | 131 | 1,867 | 54,165 | 54.3 K to 54.2 K (-0.24 %) |
May 29 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.07 | 630 | 8,864 | 54,296 | 54.9 K to 54.3 K (-1.15 %) |
May 29 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.25 | 1,569 | 22,358 | 651,270 | 652.8 K to 651.3 K (-0.24 %) |
May 29 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.07 | 7,570 | 106,510 | 652,839 | 660.4 K to 652.8 K (-1.15 %) |
May 23 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Option Exercise | M | 2.10 | 5,000 | 10,500 | 18,560 | |
May 23 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Buy | M | 2.10 | 5,000 | 10,500 | 17,722 | 12.7 K to 17.7 K (+39.30 %) |
May 23 2013 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Option Exercise | M | 3.55 | 2,700 | 9,585 | 60,000 | |
May 23 2013 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Buy | M | 3.55 | 2,700 | 9,585 | 2,700 | 0 to 2.7 K |
May 22 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.39 | 1,259 | 18,117 | 54,926 | 56.2 K to 54.9 K (-2.24 %) |
May 22 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.31 | 845 | 12,092 | 56,185 | 57 K to 56.2 K (-1.48 %) |
May 22 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.42 | 967 | 13,944 | 57,030 | 58 K to 57 K (-1.67 %) |
May 22 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.39 | 15,141 | 217,879 | 660,409 | 675.6 K to 660.4 K (-2.24 %) |
May 22 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.31 | 10,155 | 145,318 | 675,550 | 685.7 K to 675.6 K (-1.48 %) |
May 22 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.42 | 11,633 | 167,748 | 685,705 | 697.3 K to 685.7 K (-1.67 %) |
May 22 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 14.17 | 483 | 6,844 | 12,722 | 13.2 K to 12.7 K (-3.66 %) |
May 21 2013 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Option Exercise | M | 3.55 | 17,300 | 61,415 | 62,700 | |
May 21 2013 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Sell | S | 14.42 | 17,300 | 249,466 | 0 | 17.3 K to 0 (-100.00 %) |
May 21 2013 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Buy | M | 3.55 | 17,300 | 61,415 | 17,300 | 0 to 17.3 K |
May 20 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.37 | 1,121 | 16,109 | 57,997 | 59.1 K to 58 K (-1.90 %) |
May 20 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.44 | 1,735 | 25,053 | 59,118 | 60.9 K to 59.1 K (-2.85 %) |
May 20 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.37 | 13,479 | 193,693 | 697,338 | 710.8 K to 697.3 K (-1.90 %) |
May 20 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.44 | 20,865 | 301,291 | 710,817 | 731.7 K to 710.8 K (-2.85 %) |
May 16 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.43 | 1,536 | 22,164 | 60,853 | 62.4 K to 60.9 K (-2.46 %) |
May 16 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.94 | 1,551 | 23,172 | 62,389 | 63.9 K to 62.4 K (-2.43 %) |
May 16 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.43 | 18,464 | 266,436 | 731,682 | 750.1 K to 731.7 K (-2.46 %) |
May 16 2013 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 14.94 | 18,649 | 278,616 | 750,146 | 768.8 K to 750.1 K (-2.43 %) |
May 16 2013 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Sell | S | 14.70 | 5,000 | 73,500 | 10,073 | 15.1 K to 10.1 K (-33.17 %) |
May 08 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 13.51 | 500 | 6,755 | 13,205 | 13.7 K to 13.2 K (-3.65 %) |
May 03 2013 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Sell | S | 13.88 | 500 | 6,940 | 29,154 | 29.7 K to 29.2 K (-1.69 %) |
Apr 18 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 13.22 | 500 | 6,610 | 13,705 | 14.2 K to 13.7 K (-3.52 %) |
Apr 03 2013 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Sell | S | 12.54 | 500 | 6,270 | 29,654 | 30.2 K to 29.7 K (-1.66 %) |
Apr 03 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 12.48 | 500 | 6,240 | 14,205 | 14.7 K to 14.2 K (-3.40 %) |
Mar 29 2013 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Sell | S | 12.00 | 1,500 | 18,000 | 30,154 | 31.7 K to 30.2 K (-4.74 %) |
Mar 27 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 11.00 | 1,000 | 11,000 | 14,705 | 15.7 K to 14.7 K (-6.37 %) |
Mar 18 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Option Exercise | M | 1.91 | 12,722 | 24,299 | 0 | |
Mar 18 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Buy | M | 1.91 | 12,722 | 24,299 | 15,705 | 3 K to 15.7 K (+426.48 %) |
Feb 26 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 3.05 | 1,993 | 6,079 | 6,609 | |
Feb 26 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 109 | 277 | 655 | |
Feb 26 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.70 | 1,993 | 19,332 | 0 | 2 K to 0 (-100.00 %) |
Feb 26 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 3.05 | 1,993 | 6,079 | 1,993 | 0 to 2 K |
Feb 26 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.70 | 109 | 1,057 | 0 | 109 to 0 (-100.00 %) |
Feb 26 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 109 | 277 | 109 | 0 to 109 |
Feb 21 2013 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Option Exercise | A | 9.86 | 70,000 | 690,200 | 70,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Option Exercise | A | 9.86 | 14,362 | 141,609 | 14,362 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Option Exercise | A | 9.86 | 60,000 | 591,600 | 60,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Option Exercise | A | 9.86 | 70,000 | 690,200 | 70,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Meek David D. | Chief Commercial Of ... | Option Exercise | A | 9.86 | 70,000 | 690,200 | 70,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | A | 9.86 | 70,000 | 690,200 | 70,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | A | 9.86 | 60,000 | 591,600 | 60,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | A | 9.86 | 70,000 | 690,200 | 70,000 | |
Feb 21 2013 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | A | 9.86 | 220,000 | 2,169,200 | 220,000 | |
Feb 20 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 10.03 | 500 | 5,015 | 2,983 | 3.5 K to 3 K (-14.36 %) |
Feb 20 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 10.00 | 500 | 5,000 | 3,483 | 4 K to 3.5 K (-12.55 %) |
Feb 04 2013 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 10.00 | 1,000 | 10,000 | 3,983 | 5 K to 4 K (-20.07 %) |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 3.05 | 1,659 | 5,060 | 8,602 | |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 443 | 1,125 | 764 | |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 107 | 272 | 215 | |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.56 | 1,659 | 15,860 | 0 | 1.7 K to 0 (-100.00 %) |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 3.05 | 1,659 | 5,060 | 1,659 | 0 to 1.7 K |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.56 | 443 | 4,235 | 0 | 443 to 0 (-100.00 %) |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 443 | 1,125 | 443 | 0 to 443 |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.56 | 107 | 1,023 | 0 | 107 to 0 (-100.00 %) |
Jan 29 2013 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 107 | 272 | 107 | 0 to 107 |
Jan 08 2013 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Option Exercise | A | 9.63 | 28,000 | 269,640 | 28,000 | |
Jan 03 2013 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Sell | S | 8.75 | 6,000 | 52,500 | 31,654 | 37.7 K to 31.7 K (-15.93 %) |
Dec 28 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 2,102 | 5,339 | 1,207 | |
Dec 28 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 107 | 272 | 322 | |
Dec 28 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.05 | 2,102 | 19,023 | 0 | 2.1 K to 0 (-100.00 %) |
Dec 28 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 2,102 | 5,339 | 2,102 | 0 to 2.1 K |
Dec 28 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.05 | 107 | 968 | 0 | 107 to 0 (-100.00 %) |
Dec 28 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 107 | 272 | 107 | 0 to 107 |
Dec 20 2012 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 9.65 | 2,000 | 19,300 | 4,983 | 7 K to 5 K (-28.64 %) |
Dec 13 2012 | ECYT | ENDOCYTE INC | SANDERLING VENTURES MANAGEMENT ... | 10% Owner | Sell | J | 0.00 | 33,944 | 0 | 0 | 33.9 K to 0 (-100.00 %) |
Dec 13 2012 | ECYT | ENDOCYTE INC | SANDERLING VENTURES MANAGEMENT ... | 10% Owner | Sell | J | 0.00 | 149,003 | 0 | 0 | 149 K to 0 (-100.00 %) |
Nov 27 2012 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 9.00 | 2,000 | 18,000 | 6,983 | 9 K to 7 K (-22.26 %) |
Nov 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 1,926 | 4,892 | 3,309 | |
Nov 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 283 | 719 | 429 | |
Nov 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 8.72 | 1,926 | 16,795 | 0 | 1.9 K to 0 (-100.00 %) |
Nov 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 1,926 | 4,892 | 1,926 | 0 to 1.9 K |
Nov 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 8.72 | 283 | 2,468 | 0 | 283 to 0 (-100.00 %) |
Nov 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 283 | 719 | 283 | 0 to 283 |
Nov 05 2012 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Sell | S | 9.40 | 5,000 | 47,000 | 8,983 | 14 K to 9 K (-35.76 %) |
Oct 29 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 2,209 | 5,611 | 712 | |
Oct 29 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 9.71 | 2,209 | 21,449 | 0 | 2.2 K to 0 (-100.00 %) |
Oct 29 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 2,209 | 5,611 | 2,209 | 0 to 2.2 K |
Oct 01 2012 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Sell | S | 9.99 | 34,000 | 339,810 | 385,117 | 419.1 K to 385.1 K (-8.11 %) |
Oct 01 2012 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Gift | G | 0.00 | 15,000 | 0 | 419,117 | 434.1 K to 419.1 K (-3.46 %) |
Sep 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | M | 2.54 | 2,209 | 5,611 | 2,921 | |
Sep 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Sell | S | 10.28 | 2,209 | 22,709 | 0 | 2.2 K to 0 (-100.00 %) |
Sep 27 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Buy | M | 2.54 | 2,209 | 5,611 | 2,209 | 0 to 2.2 K |
Aug 17 2012 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Sell | S | 9.65 | 10,000 | 96,535 | 15,073 | 25.1 K to 15.1 K (-39.88 %) |
Aug 07 2012 | ECYT | ENDOCYTE INC | Meek David D. | Chief Commercial Of ... | Option Exercise | A | 8.73 | 160,000 | 1,396,800 | 160,000 | |
Jul 26 2012 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 7.71 | 20,000 | 154,200 | 20,000 | |
Jun 07 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.60 | 24,181 | 159,674 | 63,940 | 88.1 K to 63.9 K (-27.44 %) |
Jun 07 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.60 | 783 | 5,170 | 88,121 | 88.9 K to 88.1 K (-0.88 %) |
Jun 07 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.60 | 290,719 | 1,919,705 | 768,795 | 1.1 M to 768.8 K (-27.44 %) |
Jun 07 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.60 | 9,417 | 62,180 | 1,059,514 | 1.1 M to 1.1 M (-0.88 %) |
Jun 04 2012 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Option Exercise | A | 6.43 | 10,000 | 64,300 | 10,000 | |
Jun 04 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 6.43 | 10,000 | 64,300 | 10,000 | |
Jun 04 2012 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Option Exercise | A | 6.43 | 10,000 | 64,300 | 10,000 | |
Jun 04 2012 | ECYT | ENDOCYTE INC | BAILEY DOUGLAS G | Director | Option Exercise | A | 6.43 | 10,000 | 64,300 | 10,000 | |
Jun 04 2012 | ECYT | ENDOCYTE INC | APLIN JOHN C | Director | Option Exercise | A | 6.43 | 10,000 | 64,300 | 10,000 | |
Jun 04 2012 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Option Exercise | A | 6.43 | 10,000 | 64,300 | 10,000 | |
Jun 04 2012 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Option Exercise | A | 6.43 | 20,000 | 128,600 | 20,000 | |
May 18 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.65 | 2,142 | 14,246 | 91,975 | 94.1 K to 92 K (-2.28 %) |
May 18 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.65 | 25,758 | 171,306 | 1,105,860 | 1.1 M to 1.1 M (-2.28 %) |
May 16 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.68 | 3,071 | 20,510 | 91,046 | 94.1 K to 91 K (-3.26 %) |
May 16 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.94 | 8,215 | 56,974 | 94,117 | 102.3 K to 94.1 K (-8.03 %) |
May 16 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.68 | 36,929 | 246,638 | 1,094,689 | 1.1 M to 1.1 M (-3.26 %) |
May 16 2012 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Sell | S | 6.94 | 98,785 | 685,113 | 1,131,618 | 1.2 M to 1.1 M (-8.03 %) |
Mar 02 2012 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Option Exercise | A | 3.55 | 16,073 | 57,059 | 16,073 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Option Exercise | A | 3.55 | 100,000 | 355,000 | 100,000 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Ritter Allen R | VP of Manufacturing ... | Option Exercise | A | 3.55 | 70,000 | 248,500 | 70,000 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Nguyen Binh | VP of Clinical Affa ... | Option Exercise | A | 3.55 | 80,000 | 284,000 | 80,000 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | A | 3.55 | 80,000 | 284,000 | 80,000 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Lovejoy Chandra D | VP of Regulatory Af ... | Option Exercise | A | 3.55 | 70,000 | 248,500 | 70,000 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | A | 3.55 | 80,000 | 284,000 | 80,000 | |
Mar 02 2012 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | A | 3.55 | 200,000 | 710,000 | 200,000 | |
Dec 22 2011 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Buy | P | 3.18 | 916 | 2,913 | 75,000 | 74.1 K to 75 K (+1.24 %) |
Dec 22 2011 | ECYT | ENDOCYTE INC | Sanderling Venture Partners V, ... | 10% Owner | Buy | P | 3.16 | 217,800 | 688,248 | 871,461 | 653.7 K to 871.5 K (+33.32 %) |
Dec 22 2011 | ECYT | ENDOCYTE INC | Sanderling Venture Partners V, ... | 10% Owner | Buy | P | 3.20 | 217,800 | 696,960 | 653,661 | 435.9 K to 653.7 K (+49.97 %) |
Dec 22 2011 | ECYT | ENDOCYTE INC | SANDERLING VENTURES MANAGEMENT ... | 10% Owner | Buy | P | 3.16 | 2,200 | 6,952 | 35,166 | 33 K to 35.2 K (+6.67 %) |
Dec 22 2011 | ECYT | ENDOCYTE INC | SANDERLING VENTURES MANAGEMENT ... | 10% Owner | Buy | P | 3.20 | 2,200 | 7,040 | 32,966 | 30.8 K to 33 K (+7.15 %) |
Dec 21 2011 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Buy | P | 3.13 | 24,084 | 75,383 | 74,084 | 50 K to 74.1 K (+48.17 %) |
Dec 19 2011 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Buy | P | 3.16 | 50,000 | 158,000 | 50,000 | 0 to 50 K |
Dec 21 2011 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Buy | P | 3.14 | 5,000 | 15,700 | 25,073 | 20.1 K to 25.1 K (+24.91 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | BAILEY DOUGLAS G | Director | Buy | P | 3.36 | 125,000 | 420,000 | 198,297 | 73.3 K to 198.3 K (+170.54 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | M | 2.54 | 15,000 | 38,100 | 0 | |
Dec 16 2011 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | M | 0.19 | 6,998 | 1,330 | 0 | |
Dec 16 2011 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Buy | M | 2.54 | 15,000 | 38,100 | 37,654 | 22.7 K to 37.7 K (+66.21 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Buy | M | 0.19 | 6,998 | 1,330 | 22,654 | 15.7 K to 22.7 K (+44.70 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | APLIN JOHN C | Director | Buy | P | 3.27 | 20,000 | 65,400 | 21,063 | 1.1 K to 21.1 K (+1,881.47 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | P | 3.20 | 400 | 1,280 | 434,117 | 433.7 K to 434.1 K (+0.09 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | P | 3.21 | 600 | 1,926 | 433,717 | 433.1 K to 433.7 K (+0.14 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Option Exercise | M | 2.10 | 7,853 | 16,491 | 0 | |
Dec 16 2011 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Option Exercise | M | 1.91 | 13,089 | 25,000 | 0 | |
Dec 16 2011 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Buy | M | 2.10 | 7,853 | 16,491 | 93,217 | 85.4 K to 93.2 K (+9.20 %) |
Dec 16 2011 | ECYT | ENDOCYTE INC | Sherman Michael A. | Chief Financial Off ... | Buy | M | 1.91 | 13,089 | 25,000 | 85,364 | 72.3 K to 85.4 K (+18.11 %) |
Aug 09 2011 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | M | 0.19 | 14 | 3 | 0 | |
Aug 09 2011 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Buy | M | 0.19 | 14 | 3 | 15,656 | 15.6 K to 15.7 K (+0.09 %) |
May 31 2011 | ECYT | ENDOCYTE INC | Shannon James Samuel | Director | Option Exercise | A | 11.80 | 10,000 | 118,000 | 10,000 | |
May 31 2011 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Option Exercise | A | 11.80 | 10,000 | 118,000 | 10,000 | |
May 31 2011 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | A | 11.80 | 20,000 | 236,000 | 20,000 | |
May 31 2011 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 11.80 | 10,000 | 118,000 | 10,000 | |
May 31 2011 | ECYT | ENDOCYTE INC | CLAWSON JOHN G | Director | Option Exercise | A | 11.80 | 10,000 | 118,000 | 10,000 | |
May 31 2011 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Option Exercise | A | 11.80 | 10,000 | 118,000 | 10,000 |